VOR - Vor Biopharma Inc.
15.12
0.560 3.704%
Share volume: 544,630
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$14.56
0.56
0.04%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-20-2025 | 05-14-2025 | 11-13-2025 | |
| Cash flow financing | 53.286 M | -606.000 K | 21.549 M | |
| Other financing cash flows | -2.355 M | -55.000 K | -19.000 K | |
| Cash flow | 29.151 M | -31.902 M | -32.357 M | |
| Net income | -30.712 M | -32.486 M | -812.684 M | |
| Depreciation | 865.000 K | 825.000 K | 2.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -72.000 K | -230.000 K | -244.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 72.000 K | 231.000 K | 244.000 K | |
| Cash Change | 29.151 M | -31.902 M | -32.357 M |